Bio-Rad Laboratories, Inc. logo
Bio-Rad Laboratories, Inc. (BIO)
Compare

Bio-Rad Laboratories, Inc. (BIO) Enterprise Value (EV): $9.26B

The enterprise value (EV) for Bio-Rad Laboratories, Inc. (BIO) is $9.26B as of Wednesday, June 10, 2026.

BIO Enterprise Value (EV) Metrics

ENTERPRISE VALUE (EV)

$9.26B

BIO Competitors' Enterprise Value (EV)

NAMEMARKET CAPENTERPRISE VALUE (EV)
Bio-Rad Laboratories, Inc. (BIO)$7.89B$9.26B
Charles River Laboratories International, Inc. (CRL)$9.06B$12.95B
Hims & Hers Health, Inc. (HIMS)$6.42B$8.34B
Baxter International Inc. (BAX)$10.49B$17.84B
Align Technology, Inc. (ALGN)$12.56B$10.36B
Hologic, Inc. (HOLX)$16.97B$15.94B
Moderna, Inc. (MRNA)$18.40B$10.79B
BioNTech SE (BNTX)$21.81B$14.31B
Mettler-Toledo International Inc. (MTD)$22.85B$31.01B
Waters Corporation (WAT)$23.83B$23.51B

Enterprise Value Calculation

Market Cap

$7.89B

+

Total Debt

$1.38B

Cash

$531.80M

=

Enterprise Value

$9.26B

EV-Based Valuation Multiples

Why use EV instead of Market Cap?

  • EV accounts for debt - an acquirer must pay or assume it
  • EV deducts cash - the acquirer effectively receives it
  • EV enables fair comparison of companies with different capital structures
  • EV-based ratios (EV/EBITDA, EV/Sales) are capital structure neutral

Bio-Rad Laboratories, Inc. Enterprise Value (EV) Formula & Definition

Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Bio-Rad Laboratories, Inc. Enterprise Value (EV) FAQ

What is the enterprise value (EV) for Bio-Rad Laboratories, Inc. (BIO)?
The enterprise value (EV) for BIO stock is $9.26B.

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.

Hercules, CA
7,700 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Norman D. Schwartz